Home  »  Business   »  Thinking Of Selling Johnson & Johnson (NYSE: ...

Thinking Of Selling Johnson & Johnson (NYSE: JNJ) Stock? Read This First.

Johnson & Johnson (NYSE:JNJ) shares, rose in value on Thursday, May 25, with the stock price down by -1.07% to the previous day’s close as strong demand from buyers drove the stock to $154.98.

Actively observing the price movement in the recent trading, the stock is buoying the session at $156.66, falling within a range of $155.92 and $157.14. The value of beta (5-year monthly) is 0.53 whereas the PE ratio is 32.77 over 12-month period. Referring to stock’s 52-week performance, its high was $183.35, and the low was $150.11. On the whole, JNJ has fluctuated by -4.70% over the past month.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


With the market capitalization of Johnson & Johnson currently standing at about $406.02 billion, investors are eagerly awaiting this quarter’s results, scheduled for Jul 20, 2023. The company’s Forward Dividend Ratio is 4.76, with its dividend yield at 3.04%.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that JNJ’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 7.55, with the price of JNJ currently trading nearly -3.60% and -2.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 29.86, while the 7-day volatility ratio is showing 1.10% which for the 30-day chart, stands at 1.16%. Furthermore, Johnson & Johnson (JNJ)’s beta value is 0.54, and its average true range (ATR) is 2.03.

A comparison of Johnson & Johnson (JNJ) with its peers suggests the former has fared considerably weaker in the market. JNJ showed an intraday change of -1.07% in today’s session so far, and over the past year, it shrunk by -14.56%%. In comparison, The Procter & Gamble Company (PG) has moved lower at -0.35% today and is down -1.22% over the past 12 months. On the other hand, the price of Rogers Corporation (ROG) has risen 1.19% today. The stock, however, is off -40.24% from where it was a year ago. The PE ratio stands at 32.77 for Johnson & Johnson, compared to 25.48 for The Procter & Gamble Company, and 30.04 for Rogers Corporation. Other than that, the overall performance of the S&P 500 during the today’s session so far shows that it gained 0.77%. Meanwhile, the Dow Jones Industrial Slipped by -0.15%.

Data on historical trading for Johnson & Johnson (NYSE:JNJ) indicates that the trading volumes over the past 10 days have averaged 5.55 million and over the past 3 months, they’ve averaged 7.25 million. According to company’s latest data on outstanding shares, there are 2.61 billion shares outstanding.

Nearly 0.10% of Johnson & Johnson’s shares belong to company insiders and institutional investors own 70.80% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 13.48 million shares as on May 14, 2023, resulting in a short ratio of 2.09. According to the data, the short interest in Johnson & Johnson (JNJ) stood at 0.52% of shares outstanding as of May 14, 2023; the number of short shares registered in Apr 13, 2023 reached 14.07 million. The stock has fallen by -12.27% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the JNJ stock heading into the next quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *